Top 20 Companies in API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market: Global Share, Market Size, Revenue Report (2024–2035)
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
According to a research report published by Spherical Insights & Consulting, the Global API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market Size is projected to grow from USD 1.78 Billion in 2024 to USD 3.028 Billion by 2035, at a CAGR of 4.85% during the forecast period 2024–2035. The API chondroitin sulfate hyaluronic acid pancreatin market is driven by the rising prevalence of chronic conditions like osteoarthritis, increasing demand for joint health supplements, and a surge in pharmaceutical applications. The market is also propelled by an aging global population, growing interest in preventive care, and expansion of nutraceutical applications.
Introduction
The API chondroitin sulfate hyaluronic acid pancreatin market encompasses the production and supply of these raw, bioactive substances used in pharmaceuticals, nutraceuticals, and cosmetics. These ingredients are critical for treating joint disorders, skin care, and digestive health. As of the current 2025-2026 market analysis, it can still be inferred that China is one of the largest producers/exporters of chondroitin sulfate however, according to various sources, their market share might actually be over 12% in terms of global production volume. Based on recent reports, China is the largest global producer/exporter of chondroitin, being responsible for about 78% - 90% total world supply.
The Indian Administration has approved its Manufacturing of Key Starting Materials (KSM) and Active Pharmaceutical Ingredients (API) Production Linked Incentive (PLI) Program with an investment outlay of Rs 6,940 crores (bn) for Fiscal Years 2023 through to Fiscal Year 2029-2030, to improve manufacturing in India for 41 specified critical products. The API chondroitin sulfate hyaluronic acid pancreatin market consists of several opportunities, such as the growing demand for joint health and osteoarthritis management, shift towards high-purity pharmaceutical-grade APIs, development of sustainable and non-animal sources, and innovation in combination therapies and drug delivery.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market.
Market Segmentation
Global API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market Size, Share, By Application (Pharmaceuticals, Nutraceuticals, Cosmetics, and Dietary Supplements), By Form (Powder, Liquid, Capsule, Tablet), By Source (Animal Source, Plant Source, Synthetic Source), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035
API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market & Statistics
- The Market Size for API Chondroitin Sulfate Hyaluronic Acid Pancreatin Was Estimated to be worth USD 1.78 Billion in 2024.
- The Market is Going to Expand at a CAGR of 4.85% between 2025 and 2035.
- The Global API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market Size is anticipated to reach USD 3.028 Billion by 2035.
- North America is expected to generate the largest demand during the forecast period in the API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market.
- Asia Pacific is expected to grow the fastest during the forecast period in the Global API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the API chondroitin sulfate hyaluronic acid pancreatin market. In April 2025, Lesaffre’s Gnosis created MyCondro, a type of chondroitin sulfate made from fermentation that can be purified extensively, guaranteed to meet all your quality needs, and will be easy for your body to absorb as a nutraceutical or as an aid to improve joint health.
In 2025, Porcine-derived pancreatin continues to dominate the global market due to its high enzymatic efficiency, particularly in lipase activity, and its widespread use in pancreatic enzyme replacement therapies. Key manufacturers are focusing on high-potency and specialty-grade formulations to address growing demand in pharmaceutical and clinical nutrition applications. The Asia Pacific region dominated the API chondroitin sulfate hyaluronic acid pancreatin market due to low-cost, high-volume production in China and India, expanding pharmaceutical industries, increasing prevalence of osteoarthritis, and high demand for anti-aging cosmetic products, and was supported by favorable government regulations.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market.
North America is expected to generate the largest demand during the forecast period in the API chondroitin sulfate hyaluronic acid pancreatin market. North America holds a major share of the global API chondroitin sulfate hyaluronic acid pancreatin market for these APIs, fueled by an aging population and increasing demand for dietary supplements and joint health products. In March 2025, Advanced formulations combining hyaluronic acid and chondroitin sulfate in medical and therapeutic applications have gained traction, improving bioavailability and treatment outcomes in gastrointestinal and joint-related conditions.
In 2024 (Ongoing Trend), market players are increasingly introducing innovative delivery formats such as liquid supplements, gummies, and combination therapies containing chondroitin sulfate and hyaluronic acid to enhance consumer adoption in North America.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market.
Top 10 trends in the API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market
- Surging demand for combination formulations
- Focus on high-purity & pharmaceutical-grade API
- Rise of sustainable and marine-sourced ingredients
- Growth in pet nutrition & veterinary care
- Expansion into cosmetics & skincare
- Dominance of APAC in production
- Increased prevalence of osteoarthritis
- E-commerce and direct-to-consumer (DTC) growth
- Stringent regulatory scrutiny on sourcing
- Preventive health approach
- Surging demand for combination formulations
Chondroitin sulfate is often combined with glucosamine, hyaluronic acid, MSM, and collagen to provide additional benefits for joint health.
2.Focus on high-purity & pharmaceutical-grade API
Growth due to manufacturers moving towards making their APIs (Active Pharmaceutical Ingredients) with high purity levels and heavy certification levels to comply with strict regulatory guidelines (FDA, EMA).
3.Rise of sustainable and marine-sourced ingredients
There has been a change away from using bovine (cow) sourced chondroitin to using marine (fish, shark) and synthetic sources of chondroitin due to ethical and ecological considerations.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market.
4.Growth in pet nutrition & veterinary care
Pet ownership is increasing, and the interest in pet joint health is resulting in a tremendous increase in demand for chondroitin and hyaluronic acid for animal dietary supplements.
5 .Expansion into cosmetics & skincare
The need for hyaluronic acid, which is increasing due to the need for anti-aging and moisturizing skin care products, and the use of chondroitin in dermatological applications is also growing.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the API chondroitin sulfate hyaluronic acid pancreatin market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 20 Companies Leading the API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market
- Bioiberica S.A.U.
- Summit Nutritionals International, Inc.
- TSI Group Ltd.
- Yantai Dongcheng Pharmaceutical Group Co., Ltd
- Shandong Runxin Biotechnology Co., Ltd.
- Sioux Pharm, Inc.
- Seikagaku Corporation
- Nordmark Arzneimittel GmbH & Co. KG
- Pacific Rainbow International, Inc.
- Synutra Ingredients
- Bioberica S.A.U
Headquarters: Barcelona, Spain
Bioiberica S.A.U. was founded in 1975 and has grown into a global life sciences company specializing in biologically derived ingredients for pharmaceutical, nutraceutical, and animal health applications. The company focuses on the production of heparin, chondroitin sulfate, and hyaluronic acid used in joint health and medical treatments. Bioiberica is known for its strong research capabilities and high-quality manufacturing standards. The company operates across more than 80 countries, serving healthcare, nutrition, and veterinary sectors. Bioiberica employs approximately 300-500 people worldwide and generates an estimated annual revenue of USD 70-80 million (2025). Its operations span Europe, North America, and Asia-Pacific, with Europe and the United States being major revenue contributors.
2.Summit Nutritionals International, Inc.
Headquarters: Salt Lake City, Utah, United States
Summit Nutritionals International Inc. was established in 2001 and manufactures specialty nutritional ingredients for dietary supplements and functional foods. The company is recognized for producing high-purity chondroitin sulfate used in joint health products. Summit Nutritionals emphasizes quality assurance, traceability, and regulatory compliance across its supply chain. It serves customers across North America, Europe, and Asia through a well-established distribution network. The company employs approximately 100-200 professionals and is estimated to generate annual revenue of around USD 50-100 million in 2025. It continues to focus on customized ingredient solutions and long-term client relationships.
3.TSI Group Ltd
Headquarters: Christchurch, New Zealand
TSI Group Ltd. was founded in 1995 and operates as a supplier of natural health ingredients for nutraceutical and pharmaceutical applications. The company focuses on marine-based and animal-derived ingredients, including chondroitin sulfate used in joint health products. TSI Group is known for its sustainable sourcing practices and consistent product quality. It serves customers across multiple international markets through its export-driven business model. The company employs approximately 150-300 people globally and generates an estimated annual revenue of USD 80-120 million (2025). Its operations span Asia-Pacific, North America, and Europe, with Asia-Pacific and the United States being major revenue contributors.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market.
4.Yantai Dongcheng Pharmaceutical Group Co., Ltd
Headquarters: Yantai, Shandong, China
Yantai Dongcheng Pharmaceutical Group Co Ltd was founded in 1998 and has developed into a leading pharmaceutical company focused on active pharmaceutical ingredients and finished dosage products. The company produces heparin, chondroitin sulfate, and nuclear medicine products used in clinical treatments. Dongcheng Pharmaceutical is known for its advanced manufacturing facilities and strong presence in the biochemical drug segment. The company operates globally, supplying to healthcare providers and pharmaceutical companies. It employs approximately 5,000+ people worldwide and generates an estimated annual revenue of USD 600-800 million (2025). Its operations span China, North America, and Europe, with China and the United States as major revenue contributors
5.Shandong Runxin Biotechnology Co., Ltd.
Headquarters: Shandong, China
Shandong Runxin Biotechnology Co Ltd was founded in 2010 and operates as a biotechnology company specializing in bioactive ingredients for pharmaceutical and nutraceutical applications. The company focuses on the production of chondroitin sulfate used in joint health supplements and medical formulations. Runxin Biotechnology is known for its cost-efficient production and consistent product quality. The company serves global clients across multiple regions. It employs approximately 200-400 people worldwide and generates an estimated annual revenue of USD 50-120 million (2025). Its operations extend across Asia-Pacific, Europe, and North America, with China and Europe being key revenue-contributing regions.
Are you ready to discover more about the API chondroitin sulfate hyaluronic acid pancreatin market?
The report provides an in-depth analysis of the leading companies operating in the global API chondroitin sulfate hyaluronic acid pancreatin market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Bioiberica S.A.U.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the API Chondroitin Sulfate Hyaluronic Acid Pancreatin Market.
- Summit Nutritionals International, Inc.
- TSI Group Ltd.
- Yantai Dongcheng Pharmaceutical Group Co., Ltd
- Shandong Runxin Biotechnology Co., Ltd.
- Sioux Pharm, Inc.
- Seikagaku Corporation
- Nordmark Arzneimittel GmbH & Co. KG
- Pacific Rainbow International, Inc.
- Synutra Ingredients
- Jiaxing Hengjie Biopharmaceutical Co., Ltd.
- HTL Biotechnology
- Shandong Topscience Biotech Co., Ltd.
- Gnosis by Lesaffre
- Titan Biotech Limited
- Provis Biolabs Pvt Ltd
- Newgen Biotech USA Inc.
- Qingdao WanTuMing Biological Products Co., Ltd
- ZPD A/S
- Arshine Pharmaceutical Co., Limited
- Others
Conclusion
The worldwide market for chondroitin sulfate hyaluronic acid pancreatin is expected to continue enhancing its potential for growth due to both increasing population aging, demand for joint health products, and broader sales within the pharmaceutical and nutraceutical industries. High levels of API purity, in addition to a growing emphasis on new product development and sustainably sourced materials will further impact competition within this market. The majority of production occurs within the Asia Pacific region, while consumption occurs predominantly in North America. Advancements in technology and ongoing government support will create a tremendous opportunity for both manufacturers and investors through 2035, as the demand for improved healthcare, along with increased interest in preventative wellness.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?